ERCC6 and cancer: These data suggested that the carriers of the ERCC6 1097Val allele, predominantly in the homozygous state, have a higher probability of developing advanced cancer, what is also indicated by the odds ratio: OR (95% CI) = 2.86 (1.36–6.05) (p = 0.0061) for the Val/Val genotype.